Suppressive Effect of CYM50358 S1P4 Antagonist on Mast Cell Degranulation and Allergic Asthma in Mice
Open Access
- 1 September 2021
- journal article
- research article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 29 (5), 492-497
- https://doi.org/10.4062/biomolther.2020.206
Abstract
Levels of sphingosine 1-phosphate (S1P), an intercellular signaling molecule, reportedly increase in the bronchoalveolar lavage fluids of patients with asthma. Although the type 4 S1P receptor, S1P(4) has been detected in mast cells, its functions have been poorly investigated in an allergic asthma model in vivo. S1P(4) functions were evaluated following treatment of CYM50358, a selective antagonist of S1P(4), in an ovalbumin-induced allergic asthma model, and antigen-induced degranulation of mast cells. CYM50358 inhibited antigen-induced degranulation in RBL-2H3 mast cells. Eosinophil accumulation and an increase of Th2 cytokine levels were measured in the bronchoalveolar lavage fluid and via the inflammation of the lungs in ovalbumin-induced allergic asthma mice. CYM50358 administration before ovalbumin sensitization and before the antigen challenge strongly inhibited the increase of eosinophils and lymphocytes in the bronchoalveolar lavage fluid. CYM50358 administration inhibited the increase of IL-4 cytokines and serum IgE levels. Histological studies revealed that CYM50358 reduced inflammatory scores and PAS (periodic acid-Schiff)-stained cells in the lungs. The pro-allergic functions of S1P(4) were elucidated using in vitro mast cells and in vivo ovalbumin-induced allergic asthma model experiments. These results suggest that S1P(4) antagonist CYM50358 may have therapeutic potential in the treatment of allergic asthma.Keywords
Funding Information
- Korean Ministry of Science, ICT and Future Planning (NRF-2020R1A4A1016142, NRF-2019R1A2C1005523)
This publication has 34 references indexed in Scilit:
- Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonistsBioorganic & Medicinal Chemistry Letters, 2012
- Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil TraffickingOnline Journal of Public Health Informatics, 2011
- Essential roles of sphingosine-1–phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edemaThe Journal of Experimental Medicine, 2010
- Amplification mechanisms for the enhancement of antigen-mediated mast cell activationImmunologic Research, 2008
- The mast cell and allergic diseases: role in pathogenesis and implications for therapyClinical & Experimental Allergy, 2007
- Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthmaNature, 2007
- Mechanisms of Airway Remodeling in AsthmaAllergology International, 2007
- Transactivation of Sphingosine-1–Phosphate Receptors by FcεRI Triggering Is Required for Normal Mast Cell Degranulation and ChemotaxisThe Journal of Experimental Medicine, 2004
- Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthmaThe FASEB Journal, 2001
- Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptorNature, 1996